2017
DOI: 10.1016/j.joca.2017.02.060
|View full text |Cite
|
Sign up to set email alerts
|

Knee osteoarthritis and the risk of premature mortality in the community: an international individual patient level meta-analysis in 9889 subjects

Abstract: sensitization, and at a site without disease (e.g., wrist), it indicates central sensitization. The Intermittent and Constant OA Pain (ICOAP) instrument assesses presence and severity of intermittent and constant pain, and for intermittent pain, its frequency. Using the knee-specific ICOAP, pain patterns were defined as: 1) no intermittent or constant pain; 2) intermittent pain only (of at least mild severity occurring at least sometimes); and 3) constant pain (of at least mild severity) with or without interm… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…The primary symptom outcome measure represented by the Western Ontario and McMaster Universities (WOMAC) score index of severity for OA of the knee in the patients treated over 1, 2 and 3 months are depicted in table (2 ). There was a progressive and significant improvement in the primary symptom outcome measure in the patients receiving curcumin who were assessed for 1, 2, and 3 months.…”
Section: Cont Table 1: Demographic and Baseline Clinical Characteristics Of Patients In The Two Treatment Groupsmentioning
confidence: 99%
See 1 more Smart Citation
“…The primary symptom outcome measure represented by the Western Ontario and McMaster Universities (WOMAC) score index of severity for OA of the knee in the patients treated over 1, 2 and 3 months are depicted in table (2 ). There was a progressive and significant improvement in the primary symptom outcome measure in the patients receiving curcumin who were assessed for 1, 2, and 3 months.…”
Section: Cont Table 1: Demographic and Baseline Clinical Characteristics Of Patients In The Two Treatment Groupsmentioning
confidence: 99%
“…OA ischaracterized by progressive degeneration of articular cartilage, osteophyte formation and joint space narrowing (1) and involves the breakdown of joint tissues in response to a number of factors, including aging, stress and obesity which lead to a fibrillation, and loss of articular cartilage (2) .The mainstay of pharmacological therapy of OA is reducing pain, inflammation and/or stiffness and cartilage protection associated with OA can help improve the joint mobility of patients with OA (3) . Herbal therapies with anti-inflammatory properties and minimum side effects are needed for the treatment of arthritis, including rheumatoid arthritis and osteoarthritis (4) .…”
Section: Introductionmentioning
confidence: 99%